Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression
MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the development and progression of cancers, including hepatocellular carcinoma (HCC). However, in the plethora of dysregulated miRNAs, it is larg...
Saved in:
Published in | Oncogene Vol. 31; no. 42; pp. 4517 - 4526 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
18.10.2012
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the development and progression of cancers, including hepatocellular carcinoma (HCC). However, in the plethora of dysregulated miRNAs, it is largely unknown which of them have a causative role in the hepatocarcinogenic process. In the present study, we first aimed to determine changes in the expression profile of miRNAs in human HCCs and to compare them with liver tumors generated in a rat model of chemically induced HCC. We found that members of the miR-100 family (miR-100, miR-99a) were downregulated in human HCCs; a similar downregulation was also observed in rat HCCs. Their reduction was paralleled by an increased expression of polo like kinase 1 (PLK1), a target of these miRNAs. The introduction of miR-100 in HCC cells impaired their growth ability and their capability to form colonies in soft agar. Next, we aimed at investigating, in the same animal model, if dysregulation of miR-100 and PLK1 is an early or late event along the multistep process of hepatocarcinogenesis. The obtained results showed that miR-100 downregulation (i) is already evident in very early preneoplastic lesions generated 9 weeks after carcinogenic treatment; (ii) is also observed in adenomas and early HCCs; and (iii) is not simply a marker of proliferating hepatocytes. To our knowledge, this is the first work unveiling the role of a miRNA family along HCC progression. |
---|---|
AbstractList | MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the development and progression of cancers, including hepatocellular carcinoma (HCC). However, in the plethora of dysregulated miRNAs, it is largely unknown which of them have a causative role in the hepatocarcinogenic process. In the present study, we first aimed to determine changes in the expression profile of miRNAs in human HCCs and to compare them with liver tumors generated in a rat model of chemically induced HCC. We found that members of the miR-100 family (miR-100, miR-99a) were downregulated in human HCCs; a similar downregulation was also observed in rat HCCs. Their reduction was paralleled by an increased expression of polo like kinase 1 (PLK1), a target of these miRNAs. The introduction of miR-100 in HCC cells impaired their growth ability and their capability to form colonies in soft agar. Next, we aimed at investigating, in the same animal model, if dysregulation of miR-100 and PLK1 is an early or late event along the multistep process of hepatocarcinogenesis. The obtained results showed that miR-100 downregulation (i) is already evident in very early preneoplastic lesions generated 9 weeks after carcinogenic treatment; (ii) is also observed in adenomas and early HCCs; and (iii) is not simply a marker of proliferating hepatocytes. To our knowledge, this is the first work unveiling the role of a miRNA family along HCC progression. [PUBLICATION ABSTRACT] MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the development and progression of cancers, including hepatocellular carcinoma (HCC). However, in the plethora of dysregulated miRNAs, it is largely unknown which of them have a causative role in the hepatocarcinogenic process. In the present study, we first aimed to determine changes in the expression profile of miRNAs in human HCCs and to compare them with liver tumors generated in a rat model of chemically induced HCC. We found that members of the miR-100 family (miR-100, miR-99a) were downregulated in human HCCs; a similar downregulation was also observed in rat HCCs. Their reduction was paralleled by an increased expression of polo like kinase 1 (PLK1), a target of these miRNAs. The introduction of miR-100 in HCC cells impaired their growth ability and their capability to form colonies in soft agar. Next, we aimed at investigating, in the same animal model, if dysregulation of miR-100 and PLK1 is an early or late event along the multistep process of hepatocarcinogenesis. The obtained results showed that miR100 downregulation (i) is already evident in very early preneoplastic lesions generated 9 weeks after carcinogenic treatment; (ii) is also observed in adenomas and early HCCs; and (iii) is not simply a marker of proliferating hepatocytes. To our knowledge, this is the first work unveiling the role of a miRNA family along HCC progression. Oncogene (2012) 31, 4517-4526; doi: 10.1038/onc.2011.631; published online 16 January 2012 Keywords: miRNA; HCC; animal model; PLK1; hepatocarcinogenesis MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the development and progression of cancers, including hepatocellular carcinoma (HCC). However, in the plethora of dysregulated miRNAs, it is largely unknown which of them have a causative role in the hepatocarcinogenic process. In the present study, we first aimed to determine changes in the expression profile of miRNAs in human HCCs and to compare them with liver tumors generated in a rat model of chemically induced HCC. We found that members of the miR-100 family (miR-100, miR-99a) were downregulated in human HCCs; a similar downregulation was also observed in rat HCCs. Their reduction was paralleled by an increased expression of polo like kinase 1 (PLK1), a target of these miRNAs. The introduction of miR-100 in HCC cells impaired their growth ability and their capability to form colonies in soft agar. Next, we aimed at investigating, in the same animal model, if dysregulation of miR-100 and PLK1 is an early or late event along the multistep process of hepatocarcinogenesis. The obtained results showed that miR-100 downregulation (i) is already evident in very early preneoplastic lesions generated 9 weeks after carcinogenic treatment; (ii) is also observed in adenomas and early HCCs; and (iii) is not simply a marker of proliferating hepatocytes. To our knowledge, this is the first work unveiling the role of a miRNA family along HCC progression. MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the development and progression of cancers, including hepatocellular carcinoma (HCC). However, in the plethora of dysregulated miRNAs, it is largely unknown which of them have a causative role in the hepatocarcinogenic process. In the present study, we first aimed to determine changes in the expression profile of miRNAs in human HCCs and to compare them with liver tumors generated in a rat model of chemically induced HCC. We found that members of the miR-100 family (miR-100, miR-99a) were downregulated in human HCCs; a similar downregulation was also observed in rat HCCs. Their reduction was paralleled by an increased expression of polo like kinase 1 (PLK1), a target of these miRNAs. The introduction of miR-100 in HCC cells impaired their growth ability and their capability to form colonies in soft agar. Next, we aimed at investigating, in the same animal model, if dysregulation of miR-100 and PLK1 is an early or late event along the multistep process of hepatocarcinogenesis. The obtained results showed that miR100 downregulation (i) is already evident in very early preneoplastic lesions generated 9 weeks after carcinogenic treatment; (ii) is also observed in adenomas and early HCCs; and (iii) is not simply a marker of proliferating hepatocytes. To our knowledge, this is the first work unveiling the role of a miRNA family along HCC progression. |
Audience | Academic |
Author | Columbano, A Salvi, A Giordano, S Petrelli, A Migliore, C Ledda-Columbano, G M Perra, A De Petro, G Benetti, A Portolani, N Schernhuber, K Ghiso, E Cargnelutti, M Barlati, S |
Author_xml | – sequence: 1 givenname: A surname: Petrelli fullname: Petrelli, A email: annalisa.petrelli@ircc.it organization: IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine – sequence: 2 givenname: A surname: Perra fullname: Perra, A organization: Department of Toxicology, Unit of Oncology and Molecular Pathology, University of Cagliari – sequence: 3 givenname: K surname: Schernhuber fullname: Schernhuber, K organization: IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine – sequence: 4 givenname: M surname: Cargnelutti fullname: Cargnelutti, M organization: IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine – sequence: 5 givenname: A surname: Salvi fullname: Salvi, A organization: Department of Biomedical Sciences and Biotechnologies, Division of Biology and Genetics, School of Medicine, University of Brescia – sequence: 6 givenname: C surname: Migliore fullname: Migliore, C organization: IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine – sequence: 7 givenname: E surname: Ghiso fullname: Ghiso, E organization: IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine – sequence: 8 givenname: A surname: Benetti fullname: Benetti, A organization: Department of Pathology, School of Medicine, University of Brescia – sequence: 9 givenname: S surname: Barlati fullname: Barlati, S organization: Department of Biomedical Sciences and Biotechnologies, Division of Biology and Genetics, School of Medicine, University of Brescia – sequence: 10 givenname: G M surname: Ledda-Columbano fullname: Ledda-Columbano, G M organization: Department of Toxicology, Unit of Oncology and Molecular Pathology, University of Cagliari – sequence: 11 givenname: N surname: Portolani fullname: Portolani, N organization: Department of Medical and Surgical Sciences, Surgical Clinic, School of Medicine, University of Brescia – sequence: 12 givenname: G surname: De Petro fullname: De Petro, G organization: Department of Biomedical Sciences and Biotechnologies, Division of Biology and Genetics, School of Medicine, University of Brescia – sequence: 13 givenname: A surname: Columbano fullname: Columbano, A email: columbano@unica.it organization: Department of Toxicology, Unit of Oncology and Molecular Pathology, University of Cagliari – sequence: 14 givenname: S surname: Giordano fullname: Giordano, S email: silvia.giordano@unito.it organization: IRCC, Institute for Cancer Research and Treatment, University of Torino School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22249248$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kkuLFDEUhYOMOD2jO9cScOPCavOoSnUth8FRsUHxsQ6p5FZNhqqkTVJC_xL_7tymxyeDhBBIvnNucnPOyEmIAQh5ytmaM7l5FYNdC8b5Wkn-gKx43aqqabr6hKxY17CqE1KckrOcbxhjbcfEI3IqhKg7UW9W5Mdn-LZAKN5M1AQz7bPPNA50XqbiczEj0GvYmRKtSdaHOEKAA5LgO5gp03JtCp39p4ozhgaOfty-59Ttc4JxmUzxMVDETaBg0rSnKAsoMD4UnOComWIYaVnmmOguxTFBzih6TB4O6A9P7tZz8vXq9ZfLt9X2w5t3lxfbyjZClgqMFRyUclzKje2kGZoeXCu4GixrXd1bKaAT_SAVcKdw5X2DZC-cUbVz8py8OPpibWxELnr22cI0mQBxyZpzgYXajZKIPv8HvYlLwp5lLVTNGy5Z91-Ko1nbslZ0v6nRTKB9GGJJxh5K6wvJ1Kbp8OuQWt9D4XAwe4sxGDzu_yV4eRTYFDN-waB3yc8m7TVn-pAWjWnRh7RoTAviz-7uuvQzuF_wz3ggUB2BjEdhhPTHY-4zvAUd8cve |
CODEN | ONCNES |
CitedBy_id | crossref_primary_10_1038_cdd_2017_106 crossref_primary_10_1007_s00535_013_0909_8 crossref_primary_10_3390_jpm13010044 crossref_primary_10_3390_cancers11121906 crossref_primary_10_1016_j_gene_2018_06_047 crossref_primary_10_1042_CS20140007 crossref_primary_10_1158_0008_5472_CAN_13_2197 crossref_primary_10_18632_oncotarget_23188 crossref_primary_10_18632_oncotarget_7021 crossref_primary_10_1016_j_anl_2012_07_001 crossref_primary_10_3390_cancers13030514 crossref_primary_10_1371_journal_pone_0064434 crossref_primary_10_1080_15376516_2017_1324932 crossref_primary_10_1186_s12935_014_0119_3 crossref_primary_10_1016_j_cellsig_2015_02_013 crossref_primary_10_1038_oncsis_2014_11 crossref_primary_10_1371_journal_pgen_1007837 crossref_primary_10_18632_oncotarget_2601 crossref_primary_10_3390_v5030858 crossref_primary_10_1016_j_phrs_2013_03_006 crossref_primary_10_1007_s13277_013_1274_1 crossref_primary_10_18632_oncotarget_2189 crossref_primary_10_3390_gidisord3040022 crossref_primary_10_1002_path_4804 crossref_primary_10_1016_j_antiviral_2018_05_008 crossref_primary_10_3892_ol_2018_9406 crossref_primary_10_1093_nar_gky696 crossref_primary_10_1242_bio_20121628 crossref_primary_10_7554_eLife_07197 crossref_primary_10_1007_s00432_015_1943_0 crossref_primary_10_1007_s13277_013_1146_8 crossref_primary_10_3390_genes13050785 crossref_primary_10_1016_j_tranon_2014_09_003 crossref_primary_10_1089_ars_2013_5514 crossref_primary_10_2217_hep_14_9 crossref_primary_10_1016_j_critrevonc_2015_01_009 crossref_primary_10_3390_cancers16010129 crossref_primary_10_1007_s13277_013_1141_0 crossref_primary_10_1016_j_bbrc_2016_08_006 crossref_primary_10_1038_gt_2013_24 crossref_primary_10_1111_hepr_12386 crossref_primary_10_1186_1746_1596_7_159 crossref_primary_10_1155_2021_9920786 crossref_primary_10_1007_s00381_017_3366_5 crossref_primary_10_1093_nar_gkx1250 crossref_primary_10_1158_1940_6207_CAPR_12_0253 crossref_primary_10_1038_s41598_018_30895_8 crossref_primary_10_1002_hep_26616 crossref_primary_10_1002_jcp_27283 crossref_primary_10_1186_s12935_022_02573_3 crossref_primary_10_1007_s11010_013_1753_0 crossref_primary_10_1007_s12032_012_0411_9 crossref_primary_10_18632_oncotarget_2962 crossref_primary_10_3892_ol_2019_10962 crossref_primary_10_1007_s13277_015_3267_8 crossref_primary_10_1080_01635581_2014_863364 crossref_primary_10_1097_QAD_0000000000002895 crossref_primary_10_1038_s41419_020_2366_7 |
Cites_doi | 10.1158/1078-0432.CCR-07-1731 10.1016/S1470-2045(09)70343-2 10.1055/s-0030-1247134 10.1186/1471-2105-8-3 10.1038/nature03702 10.1016/j.cell.2009.04.021 10.1016/j.ccr.2011.01.001 10.1053/j.gastro.2004.09.015 10.1038/sj.onc.1202018 10.1096/fj.09-152207 10.1002/ijc.22394 10.1073/pnas.82.12.3964 10.1038/sj.onc.1208273 10.1158/0008-5472.CAN-08-2886 10.1158/1078-0432.CCR-07-0666 10.1002/hep.23488 10.1038/nature08744 10.1126/science.1114519 10.1016/j.urolonc.2009.02.002 10.1016/S1470-2045(01)00486-7 10.1016/j.jhep.2011.01.042 10.1128/JVI.00961-08 10.1002/gcc.20666 10.1006/bbrc.1997.6633 10.1002/hep.22158 10.1073/pnas.1009009107 10.1038/onc.2011.63 10.1002/ijc.24880 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited 2012 COPYRIGHT 2012 Nature Publishing Group Copyright Nature Publishing Group Oct 18, 2012 Macmillan Publishers Limited 2012. |
Copyright_xml | – notice: Macmillan Publishers Limited 2012 – notice: COPYRIGHT 2012 Nature Publishing Group – notice: Copyright Nature Publishing Group Oct 18, 2012 – notice: Macmillan Publishers Limited 2012. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PQEST PQQKQ PQUKI PRINS Q9U RC3 |
DOI | 10.1038/onc.2011.631 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Research Library Prep AIDS and Cancer Research Abstracts MEDLINE Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology |
EISSN | 1476-5594 |
EndPage | 4526 |
ExternalDocumentID | 2791844761 A306859950 10_1038_onc_2011_631 22249248 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- -Q- 0R~ 123 29N 2WC 36B 39C 3O- 3V. 4.4 406 53G 5RE 70F 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AANZL AAWBL AAZLF ABAKF ABAWZ ABDBF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGEZK AGHAI AGQEE AHMBA AHSBF AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FEDTE FERAY FIZPM FRP FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ITC IWAJR JSO JZLTJ KQ8 L7B LK8 M0L M1P M2O M7P N9A NAO NQJWS NXXTH O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SNX SNYQT SOHCF SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TSG TUS UKHRP W2D WH7 ~8M AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION AADWK AATNV AAYFA AAYJO ABGIJ ACBMV ACBRV ACBYP ACIGE ACTTH ACVWB ADMDM ADQMX ADYYL AEDAW AEFTE AFNRJ AGGBP AJCLW AJDOV AMRJV NYICJ ZA5 FIGPU 7TM 7TO 7U9 7XB 8FD 8FK FR3 H94 K9. MBDVC P64 PQEST PQUKI PRINS Q9U RC3 |
ID | FETCH-LOGICAL-c523t-eac21e66d1338c93af5bed7216fc07d4bc32e92bf36e1d6bf31b538cb2da64dd3 |
IEDL.DBID | 8C1 |
ISSN | 0950-9232 |
IngestDate | Fri Aug 16 22:24:10 EDT 2024 Thu Oct 10 18:05:47 EDT 2024 Thu Oct 10 18:51:04 EDT 2024 Thu Feb 22 23:45:40 EST 2024 Fri Feb 02 04:25:35 EST 2024 Fri Sep 27 02:37:17 EDT 2024 Sun Oct 13 10:32:33 EDT 2024 Fri Oct 11 20:47:13 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 42 |
Keywords | miRNA HCC hepatocarcinogenesis animal model PLK1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c523t-eac21e66d1338c93af5bed7216fc07d4bc32e92bf36e1d6bf31b538cb2da64dd3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/onc2011631.pdf |
PMID | 22249248 |
PQID | 1112770729 |
PQPubID | 36330 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1125237863 proquest_journals_2641513093 proquest_journals_1112770729 gale_infotracmisc_A306859950 gale_infotracacademiconefile_A306859950 crossref_primary_10_1038_onc_2011_631 pubmed_primary_22249248 springer_journals_10_1038_onc_2011_631 |
PublicationCentury | 2000 |
PublicationDate | 10-18-2012 |
PublicationDateYYYYMMDD | 2012-10-18 |
PublicationDate_xml | – month: 10 year: 2012 text: 10-18-2012 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England – name: New York |
PublicationTitle | Oncogene |
PublicationTitleAbbrev | Oncogene |
PublicationTitleAlternate | Oncogene |
PublicationYear | 2012 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Cairo, Wang, de, Duroure, Dahan, Redon (CR2) 2010; 107 De Petro, Tavian, Copeta, Portolani, Giulini, Barlati (CR4) 1998; 58 Satoh, Kitahara, Soma, Inaba, Hatayama, Sato (CR22) 1985; 82 Hou, Lin, Zhou, Wang, Ding, Dong (CR9) 2011; 19 Pellegrino, Calvisi, Ladu, Ehemann, Staniscia, Evert (CR21) 2010; 51 Eckerdt, Yuan, Strebhardt (CR5) 2005; 24 Solt, Medline, Farber (CR25) 1977; 88 Ueda, Volinia, Okumura, Shimizu, Taccioli, Rossi (CR29) 2010; 11 Lee, Gusev, Jiang, Nuovo, Lerner, Frankel (CR13) 2007; 120 Shi, Alajez, Bastianutto, Hui, Mocanu, Ito (CR23) 2010; 126 Wang, Weber, Croce, Liu, Liao, Pellett (CR31) 2008; 82 Christodoulou, Raible, Tomer, Simakov, Trachana, Klaus (CR3) 2010; 463 Oneyama, Ikeda, Okuzaki, Suzuki, Kanou, Shintani (CR19) 2011; 30 Nam, Yoon, Kim, Kim, Kim, Kim (CR18) 2008; 14 Imbeaud, Ladeiro, Zucman-Rossi (CR10) 2010; 30 Thorgeirsson (CR28) 2011; 55 Ledda-Columbano, Curto, Piga, Zedda, Menegazzi, Sartori (CR12) 1998; 17 Liu, Gong, Chao, Peng, Yuan, Ma (CR16) 2009; 122 Smith, Wilson, Hamanaka, Chase, Kung, Longo (CR24) 1997; 234 Fu, Medico (CR7) 2007; 8 Henson, Bhattacharjee, O'Dee, Feingold, Gollin (CR8) 2009; 48 Kota, Chivukula, O'Donnell, Wentzel, Montgomery, Hwang (CR11) 2009; 137 Su, Yang, Xu, Huang, Xu, Yuan (CR26) 2009; 69 Lee, Thorgeirsson (CR14) 2004; 127 Parkin (CR20) 2001; 2 Enomoto, Farber (CR6) 1982; 42 Varnholt, Drebber, Schulze, Wedemeyer, Schirmacher, Dienes (CR30) 2008; 47 Lu, Getz, Miska, varez-Saavedra, Lamb, Peck (CR17) 2005; 435 Wienholds, Kloosterman, Miska, varez-Saavedra, Berezikov, de (CR32) 2005; 309 Tarantino, Paolella, Cozzuto, Minopoli, Pastore, Parisi (CR27) 2010; 24 Andersen, Loi, Perra, Factor, Ledda-Columbano, Columbano (CR1) 2010; 51 Leite, Sousa-Canavez, Reis, Tomiyama, Camara-Lopes, Sanudo (CR15) 2009; 29 Wong, Liu, Wong, Ng, Yuen, Wei (CR33) 2008; 14 GM Ledda-Columbano (BFonc2011631_CR12) 1998; 17 J Lu (BFonc2011631_CR17) 2005; 435 R Pellegrino (BFonc2011631_CR21) 2010; 51 H Su (BFonc2011631_CR26) 2009; 69 EJ Nam (BFonc2011631_CR18) 2008; 14 C Tarantino (BFonc2011631_CR27) 2010; 24 F Christodoulou (BFonc2011631_CR3) 2010; 463 W Liu (BFonc2011631_CR16) 2009; 122 K Enomoto (BFonc2011631_CR6) 1982; 42 EJ Lee (BFonc2011631_CR13) 2007; 120 MR Smith (BFonc2011631_CR24) 1997; 234 F Eckerdt (BFonc2011631_CR5) 2005; 24 S Cairo (BFonc2011631_CR2) 2010; 107 H Varnholt (BFonc2011631_CR30) 2008; 47 SS Thorgeirsson (BFonc2011631_CR28) 2011; 55 G De Petro (BFonc2011631_CR4) 1998; 58 T Ueda (BFonc2011631_CR29) 2010; 11 L Fu (BFonc2011631_CR7) 2007; 8 KR Leite (BFonc2011631_CR15) 2009; 29 J Kota (BFonc2011631_CR11) 2009; 137 S Imbeaud (BFonc2011631_CR10) 2010; 30 J Hou (BFonc2011631_CR9) 2011; 19 W Shi (BFonc2011631_CR23) 2010; 126 C Oneyama (BFonc2011631_CR19) 2011; 30 JB Andersen (BFonc2011631_CR1) 2010; 51 JS Lee (BFonc2011631_CR14) 2004; 127 E Wienholds (BFonc2011631_CR32) 2005; 309 K Satoh (BFonc2011631_CR22) 1985; 82 DB Solt (BFonc2011631_CR25) 1977; 88 BJ Henson (BFonc2011631_CR8) 2009; 48 FZ Wang (BFonc2011631_CR31) 2008; 82 DM Parkin (BFonc2011631_CR20) 2001; 2 TS Wong (BFonc2011631_CR33) 2008; 14 |
References_xml | – volume: 14 start-page: 2690 year: 2008 end-page: 2695 ident: CR18 article-title: MicroRNA expression profiles in serous ovarian carcinoma publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-1731 contributor: fullname: Kim – volume: 11 start-page: 136 year: 2010 end-page: 146 ident: CR29 article-title: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70343-2 contributor: fullname: Rossi – volume: 30 start-page: 75 year: 2010 end-page: 86 ident: CR10 article-title: Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma publication-title: Semin Liver Dis doi: 10.1055/s-0030-1247134 contributor: fullname: Zucman-Rossi – volume: 8 start-page: 3 year: 2007 ident: CR7 article-title: FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-8-3 contributor: fullname: Medico – volume: 435 start-page: 834 year: 2005 end-page: 838 ident: CR17 article-title: MicroRNA expression profiles classify human cancers publication-title: Nature doi: 10.1038/nature03702 contributor: fullname: Peck – volume: 137 start-page: 1005 year: 2009 end-page: 1017 ident: CR11 article-title: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model publication-title: Cell doi: 10.1016/j.cell.2009.04.021 contributor: fullname: Hwang – volume: 19 start-page: 232 year: 2011 end-page: 243 ident: CR9 article-title: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2011.01.001 contributor: fullname: Dong – volume: 127 start-page: S51 year: 2004 end-page: S55 ident: CR14 article-title: Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.09.015 contributor: fullname: Thorgeirsson – volume: 51 start-page: 857 year: 2010 end-page: 868 ident: CR21 article-title: Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma publication-title: Hepatology contributor: fullname: Evert – volume: 17 start-page: 1039 year: 1998 end-page: 1044 ident: CR12 article-title: hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway publication-title: Oncogene doi: 10.1038/sj.onc.1202018 contributor: fullname: Sartori – volume: 24 start-page: 3255 year: 2010 end-page: 3263 ident: CR27 article-title: miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells publication-title: FASEB J doi: 10.1096/fj.09-152207 contributor: fullname: Parisi – volume: 120 start-page: 1046 year: 2007 end-page: 1054 ident: CR13 article-title: Expression profiling identifies microRNA signature in pancreatic cancer publication-title: Int J Cancer doi: 10.1002/ijc.22394 contributor: fullname: Frankel – volume: 82 start-page: 3964 year: 1985 end-page: 3968 ident: CR22 article-title: Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.82.12.3964 contributor: fullname: Sato – volume: 24 start-page: 267 year: 2005 end-page: 276 ident: CR5 article-title: Polo-like kinases and oncogenesis publication-title: Oncogene doi: 10.1038/sj.onc.1208273 contributor: fullname: Strebhardt – volume: 42 start-page: 2330 year: 1982 end-page: 2335 ident: CR6 article-title: Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis publication-title: Cancer Res contributor: fullname: Farber – volume: 69 start-page: 1135 year: 2009 end-page: 1142 ident: CR26 article-title: MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2886 contributor: fullname: Yuan – volume: 14 start-page: 2588 year: 2008 end-page: 2592 ident: CR33 article-title: Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-0666 contributor: fullname: Wei – volume: 51 start-page: 1401 year: 2010 end-page: 1409 ident: CR1 article-title: Progenitor-derived hepatocellular carcinoma model in the rat publication-title: Hepatology doi: 10.1002/hep.23488 contributor: fullname: Columbano – volume: 88 start-page: 595 year: 1977 end-page: 618 ident: CR25 article-title: Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis publication-title: Am J Pathol contributor: fullname: Farber – volume: 463 start-page: 1084 year: 2010 end-page: 1088 ident: CR3 article-title: Ancient animal microRNAs and the evolution of tissue identity publication-title: Nature doi: 10.1038/nature08744 contributor: fullname: Klaus – volume: 309 start-page: 310 year: 2005 end-page: 311 ident: CR32 article-title: MicroRNA expression in zebrafish embryonic development publication-title: Science doi: 10.1126/science.1114519 contributor: fullname: de – volume: 29 start-page: 265 year: 2009 end-page: 269 ident: CR15 article-title: Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis publication-title: Urol Oncol doi: 10.1016/j.urolonc.2009.02.002 contributor: fullname: Sanudo – volume: 2 start-page: 533 year: 2001 end-page: 543 ident: CR20 article-title: Global cancer statistics in the year 2000 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(01)00486-7 contributor: fullname: Parkin – volume: 55 start-page: 486 year: 2011 end-page: 487 ident: CR28 article-title: The almighty MYC: orchestrating the micro-RNA universe to generate aggressive liver cancer publication-title: J Hepatol doi: 10.1016/j.jhep.2011.01.042 contributor: fullname: Thorgeirsson – volume: 82 start-page: 9065 year: 2008 end-page: 9074 ident: CR31 article-title: Human cytomegalovirus infection alters expression of cellular microRNA species that affect its replication publication-title: J Virol doi: 10.1128/JVI.00961-08 contributor: fullname: Pellett – volume: 48 start-page: 569 year: 2009 end-page: 582 ident: CR8 article-title: Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20666 contributor: fullname: Gollin – volume: 234 start-page: 397 year: 1997 end-page: 405 ident: CR24 article-title: Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1997.6633 contributor: fullname: Longo – volume: 126 start-page: 2036 year: 2010 end-page: 2048 ident: CR23 article-title: Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer publication-title: Int J Cancer contributor: fullname: Ito – volume: 47 start-page: 1223 year: 2008 end-page: 1232 ident: CR30 article-title: MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.22158 contributor: fullname: Dienes – volume: 122 start-page: 2405 year: 2009 end-page: 2411 ident: CR16 article-title: Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas publication-title: Chin Med J (Engl) contributor: fullname: Ma – volume: 58 start-page: 2234 year: 1998 end-page: 2239 ident: CR4 article-title: Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma publication-title: Cancer Res contributor: fullname: Barlati – volume: 107 start-page: 20471 year: 2010 end-page: 20476 ident: CR2 article-title: Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1009009107 contributor: fullname: Redon – volume: 30 start-page: 3489 year: 2011 end-page: 3501 ident: CR19 article-title: MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways publication-title: Oncogene doi: 10.1038/onc.2011.63 contributor: fullname: Shintani – volume: 58 start-page: 2234 year: 1998 ident: BFonc2011631_CR4 publication-title: Cancer Res contributor: fullname: G De Petro – volume: 120 start-page: 1046 year: 2007 ident: BFonc2011631_CR13 publication-title: Int J Cancer doi: 10.1002/ijc.22394 contributor: fullname: EJ Lee – volume: 30 start-page: 75 year: 2010 ident: BFonc2011631_CR10 publication-title: Semin Liver Dis doi: 10.1055/s-0030-1247134 contributor: fullname: S Imbeaud – volume: 51 start-page: 857 year: 2010 ident: BFonc2011631_CR21 publication-title: Hepatology contributor: fullname: R Pellegrino – volume: 309 start-page: 310 year: 2005 ident: BFonc2011631_CR32 publication-title: Science doi: 10.1126/science.1114519 contributor: fullname: E Wienholds – volume: 69 start-page: 1135 year: 2009 ident: BFonc2011631_CR26 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2886 contributor: fullname: H Su – volume: 19 start-page: 232 year: 2011 ident: BFonc2011631_CR9 publication-title: Cancer Cell doi: 10.1016/j.ccr.2011.01.001 contributor: fullname: J Hou – volume: 14 start-page: 2588 year: 2008 ident: BFonc2011631_CR33 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-0666 contributor: fullname: TS Wong – volume: 127 start-page: S51 year: 2004 ident: BFonc2011631_CR14 publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.09.015 contributor: fullname: JS Lee – volume: 82 start-page: 9065 year: 2008 ident: BFonc2011631_CR31 publication-title: J Virol doi: 10.1128/JVI.00961-08 contributor: fullname: FZ Wang – volume: 48 start-page: 569 year: 2009 ident: BFonc2011631_CR8 publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20666 contributor: fullname: BJ Henson – volume: 55 start-page: 486 year: 2011 ident: BFonc2011631_CR28 publication-title: J Hepatol doi: 10.1016/j.jhep.2011.01.042 contributor: fullname: SS Thorgeirsson – volume: 234 start-page: 397 year: 1997 ident: BFonc2011631_CR24 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1997.6633 contributor: fullname: MR Smith – volume: 88 start-page: 595 year: 1977 ident: BFonc2011631_CR25 publication-title: Am J Pathol contributor: fullname: DB Solt – volume: 107 start-page: 20471 year: 2010 ident: BFonc2011631_CR2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1009009107 contributor: fullname: S Cairo – volume: 463 start-page: 1084 year: 2010 ident: BFonc2011631_CR3 publication-title: Nature doi: 10.1038/nature08744 contributor: fullname: F Christodoulou – volume: 11 start-page: 136 year: 2010 ident: BFonc2011631_CR29 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70343-2 contributor: fullname: T Ueda – volume: 24 start-page: 3255 year: 2010 ident: BFonc2011631_CR27 publication-title: FASEB J doi: 10.1096/fj.09-152207 contributor: fullname: C Tarantino – volume: 14 start-page: 2690 year: 2008 ident: BFonc2011631_CR18 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-1731 contributor: fullname: EJ Nam – volume: 30 start-page: 3489 year: 2011 ident: BFonc2011631_CR19 publication-title: Oncogene doi: 10.1038/onc.2011.63 contributor: fullname: C Oneyama – volume: 42 start-page: 2330 year: 1982 ident: BFonc2011631_CR6 publication-title: Cancer Res contributor: fullname: K Enomoto – volume: 435 start-page: 834 year: 2005 ident: BFonc2011631_CR17 publication-title: Nature doi: 10.1038/nature03702 contributor: fullname: J Lu – volume: 8 start-page: 3 year: 2007 ident: BFonc2011631_CR7 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-8-3 contributor: fullname: L Fu – volume: 47 start-page: 1223 year: 2008 ident: BFonc2011631_CR30 publication-title: Hepatology doi: 10.1002/hep.22158 contributor: fullname: H Varnholt – volume: 24 start-page: 267 year: 2005 ident: BFonc2011631_CR5 publication-title: Oncogene doi: 10.1038/sj.onc.1208273 contributor: fullname: F Eckerdt – volume: 82 start-page: 3964 year: 1985 ident: BFonc2011631_CR22 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.82.12.3964 contributor: fullname: K Satoh – volume: 2 start-page: 533 year: 2001 ident: BFonc2011631_CR20 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(01)00486-7 contributor: fullname: DM Parkin – volume: 51 start-page: 1401 year: 2010 ident: BFonc2011631_CR1 publication-title: Hepatology doi: 10.1002/hep.23488 contributor: fullname: JB Andersen – volume: 29 start-page: 265 year: 2009 ident: BFonc2011631_CR15 publication-title: Urol Oncol doi: 10.1016/j.urolonc.2009.02.002 contributor: fullname: KR Leite – volume: 122 start-page: 2405 year: 2009 ident: BFonc2011631_CR16 publication-title: Chin Med J (Engl) contributor: fullname: W Liu – volume: 137 start-page: 1005 year: 2009 ident: BFonc2011631_CR11 publication-title: Cell doi: 10.1016/j.cell.2009.04.021 contributor: fullname: J Kota – volume: 126 start-page: 2036 year: 2010 ident: BFonc2011631_CR23 publication-title: Int J Cancer doi: 10.1002/ijc.24880 contributor: fullname: W Shi – volume: 17 start-page: 1039 year: 1998 ident: BFonc2011631_CR12 publication-title: Oncogene doi: 10.1038/sj.onc.1202018 contributor: fullname: GM Ledda-Columbano |
SSID | ssj0007902 |
Score | 2.3987029 |
Snippet | MicroRNAs (miRNAs) have an important role in a wide range of physiological and pathological processes, and their dysregulation has been reported to affect the... |
SourceID | proquest gale crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 4517 |
SubjectTerms | 631/208/199 631/337/384/331 631/67/1504/1610 692/420/755 Adenoma Agar Animal models Animals Apoptosis Blotting, Western Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Cell Biology Cell Cycle Proteins - genetics Cell Cycle Proteins - metabolism Cell Line, Tumor Cell Proliferation Colonies Development and progression Disease Models, Animal Disease Progression Down-Regulation Gene expression Gene Expression Profiling Gene Expression Regulation, Neoplastic Genetic aspects Genetic regulation Hepatocellular carcinoma Hepatocytes Hepatoma Human Genetics Humans Immunohistochemistry Internal Medicine Liver cancer Liver Neoplasms - genetics Liver Neoplasms - metabolism Liver Neoplasms - pathology Medicine Medicine & Public Health MicroRNA MicroRNAs MicroRNAs - genetics miRNA Neoplasm Staging Oncology original-article Pathogenesis Physiological aspects Polo-Like Kinase 1 Protein Serine-Threonine Kinases - genetics Protein Serine-Threonine Kinases - metabolism Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Rats Ribonucleic acid RNA Tumors |
Title | Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression |
URI | https://link.springer.com/article/10.1038/onc.2011.631 https://www.ncbi.nlm.nih.gov/pubmed/22249248 https://www.proquest.com/docview/1112770729 https://www.proquest.com/docview/2641513093 https://search.proquest.com/docview/1125237863 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VUFsuVbt9paUrV-rjFOE81vaeKroCobYgRIu0t8jxY0FiE1iyB35J_25nEgdYhHrKwRMnzozn4Zl8A_Apzb330rvYjiQGKKj-4rHiNrZKSCN96cuU_nc-OBT7J_mP6WgaDtyuQlllrxNbRW1rQ2fk22i40ThR3u7bxWVMXaMouxpaaKzBRoKCSa0b1OS2xEN2NYfoRfAYHZk0FL7zTG3XlenwO0WWrJik-4r5jmW6lyptLdDec3gWXEe20_H6BTxy1QAed80krwfwdNL3bhvAk4OQMn8Jf3-3xdK4kc-ZDggkrPasrSRE13Dm2CmapAZt2gLvqGek_JCEoJ1QNFlzqhs2PztGTcpxAsuOfv1MmL3GdcxC6y-G5LpijrCSWYsIxeb6rKJDB2eZPq-rGWuW83rB2mqwDgnkFZzs7f6Z7MehG0NsMFhtYtTQaeKEsBTVmnGm_ah0lrB_vOHS5qXJUjdOS58Jl1iB16REbWqQ2Vrk1mavYb2qK_cWmLCZKz3XaT7yuUq0Lg33Sa7ROXSecxvB554hxUUHulG0yfJMFci4ghhXIOMi-ErcKmgvNgttdPilAJ9CqFbFDsZDihDVeARbK5TIDrM63PO7CHv4imKjVEpCVn9w-FYgI_h4M0wTU9la5eolTZHit5NKIM2bToxuFoSOWY7Br4rgSy9Xd579wGrf_f8t3sMmUqZkVxO1BevNYuk-oMPUlENYk1M5bPfGEDa-7x4eHf8DZ_wXlw |
link.rule.ids | 315,786,790,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,74100,74369,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMoFwfIKFDASj1NUx_ba2ROqKqqF7lYIWmlvkePHtlI3Kdvsob-Ev8tM4izdquKUgx-JM-N5eMbfEPKByxCCDj51Qw0OCoi_dJQzl7pcaatDGUqO952nR2p8Ir_PhrN44HYZ0yp7mdgKaldbPCPfBcUNygnjdl8ufqdYNQqjq7GExl1yTwohkc_1bO1wMd3lHIIVwVIwZHhMfGci360r2-F3KpFtqKSbgvmaZroRKm010MFj8iiajnSvo_UTcsdXA3K_KyZ5NSDb-33ttgF5MI0h86fkz682WRo28jk1EYGE1oG2mYRgGs49PQWV1IBOW8KIeo7CD7ogtBOwJm1OTUMXZz9BkjKYwNEfk8OMuitYxzyW_qLQ3VTUI1YybRGh6MKcVXjo4B0153U1p81qUS9pmw3WIYE8IycHX4_3x2msxpBacFabFCQ0z7xSDr1aOxImDEvvEPsnWKadLK3gfsTLIJTPnIJnVoI0tUBso6Rz4jnZqurKvyRUOeHLwAyXwyDzzJjSspBJA8ahD4y5hHzsCVJcdKAbRRssF3kBhCuQcAUQLiGfkVoF7sVmaayJVwrgLYhqVeyBP5QjohpLyM5GTyCH3Wzu6V3EPXyJvhHXGpHVb23-x5AJeb9uxokxba3y9Qqn4PDvdK6gz4uOjdYLAsNMgvObJ-RTz1fX3n3Lal_9_yveke3x8XRSTL4dHb4mD2EURx2b5Ttkq1mu_BswnprybbtD_gK5gxg7 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BEaUXBMsrUMBIPE7ROk7W8Z5QtbAq9KEKqNRb5PixrdRN2m320F_C32UmcdpuVXHagx1nnRnPI_PlG4CPIvPe597FdpRjgoLmLx4rbmOrZG5yX_pS0PfOe_ty-zD7eTQ6CviniwCr7G1ia6htbegd-RAdNzonqtsNfYBFHHybfj07j6mDFFVaQzuN-_AAvaIkDVeTa7hH3uEPMaLgMQY1IoDgeaqGdWU6Lk-ZJivu6baRvuGlbpVNW280fQKPQxjJtjq5P4V7rhrAw66x5OUAHk36Pm4DWN8L5fNn8Pd3C5zGQ33KdGAjYbVnLaoQw8SZY8fonhr0bwu8op6RIcQpRPOEasqaY92w-ckvtKocF7DsYHcnYfYS9zELbcAYTtcVc8SbzFp2KDbXJxW9gHCW6dO6mrFmOa8XrEWGdawgz-Fw-v3PZDsOnRlig4lrE6O1FomT0lKGa8ap9qPSWeIB8obnNitNKtxYlD6VLrESf5MSLatBwWuZWZu-gLWqrtwrYNKmrvRci2zkM5VoXRruk0xjoOg85zaCT71AirOOgKNoC-epKlBwBQmuQMFF8IWkVdC5bBba6PB5Ad6FGK6KLcyNFLGr8Qg2V2aiOMzqcC_vIpznC8qTRJ4Ty_qdw9fKGcGHq2FamCBslauXtITAZ5criXNedmp0tSEM0jJMhFUEn3u9unHvO3b7-v__4j2s4-Eodn_s77yBDbxIkLtN1CasNYule4txVFO-aw_IP7I9HEQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sequential+analysis+of+multistage+hepatocarcinogenesis+reveals+that+miR-100+and+PLK1+dysregulation+is+an+early+event+maintained+along+tumor+progression&rft.jtitle=Oncogene&rft.au=Petrelli%2C+A&rft.au=Perra%2C+A&rft.au=Schernhuber%2C+K&rft.au=Cargnelutti%2C+M&rft.date=2012-10-18&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=31&rft.issue=42&rft.spage=4517&rft_id=info:doi/10.1038%2Fonc.2011.631&rft.externalDocID=A306859950 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |